SubHero Banner
Text

April 2018

Core topics in this month’s edition include:

  • Crysvita (burosumab-twza) - new orphan drug approval
  • Olysio (simeprevir) – drug discontinuation
  • Zavesca (miglustat) - first time generic

Download PDF

Text